GCNT1P1

Across TCGA pan-cancer cohorts, GCNT1P1 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of GCNT1P1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where GCNT1P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GCNT1P1 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

KIRC, COAD, and PAAD are the cancer types where GCNT1P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GCNT1P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.048	.010	5	view →
COAD	Female	All	+0.054	.016	3	view →
PAAD	Male	All	+0.229	.001	2	view →
CHOL	All	All	+0.092	.012	2	view →
PRAD	All	All	+0.081	.029	2	view →
KICH	All	All	−0.065	.016	2	view →
STAD	Male	All	+0.112	.036	1	view →
BLCA	Female	III,IV	+0.057	.033	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

GCNT1P1–KIRC

Open the KIRC breakdown →